Aphaia's scientific approach is so different from the mainstream that they couldn't rely on existing market understanding. Their co-founder actively toured conferences and participated in interviews to tell their story repeatedly. This educational campaign was crucial for building trust and getting stakeholders to "buy into" their completely new therapeutic concept.

When critics use a single, emotional story to attack a company, responding with aggregate data is a losing strategy. The human brain prioritizes narrative over statistics. The only effective defense is to proactively deploy your own powerful, positive stories about real people your product helps.

Management teams use compelling positive examples to build conviction. To avoid being swayed by a single, unrepresentative story, an investor must immediately ask for a negative counter-example, such as why a customer was lost. This provides a more balanced perspective.

During difficult periods, such as a failed clinical trial, the worst action a company can take is to cease communication. Continuously talking to investors, even when the news is bad, maintains trust and demonstrates resilience. Transparency in tough times is crucial for long-term investor relationships.

A key piece of advice for Apogee's CEO was to resist investor pressure to set overly ambitious timelines. By setting your own reasonable expectations and then exceeding them, you control the narrative and build credibility, which is especially critical for young, first-time leaders who face inherent skepticism.

When leading a company with a controversial product, like surveillance tech, the CEO must proactively own the narrative. Instead of using hyperbolic language to attack critics, they should repeatedly and transparently address legitimate concerns about privacy and abuse to avoid debating in bad faith.

Ona Therapeutics' CEO stresses that honesty, even admitting a lack of data, is crucial when fundraising. Investors are trained to detect dishonesty. Acknowledging what you don't know and explaining your plan to find out is more effective and builds more credibility than bluffing your way through a tough question.

To stop a persistent negative line of questioning, use specific internal statistics. For example, responding to claims of poor quality with a five-star rating figure. Journalists are less likely to challenge hard data they cannot immediately disprove.

While a CEO's personal connection to a disease provides powerful motivation, it can raise investor concerns about objectivity. Zag Bio's CEO addresses this by emphasizing a rigorously data-driven approach to all pipeline decisions, ensuring patient focus does not lead to biased choices.